This article is more than 5 years old. Information may no longer be current.

B. Braun Medical to acquire bloodlines business

Issue: September 2018

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

B. Braun Medical Inc. has signed an agreement to acquire the bloodlines business operated under the Medisystems name by NxStage Medical Inc., according to a press release from the company.

“We are pleased to add the Streamline bloodline to our dialysis product portfolio,” Sam Amory, vice president of B. Braun Medical, said in the press release. “Although we have been selling Streamline for many years, this acquisition will allow us to more broadly promote Streamline’s benefits as part of our transformative system of products, which includes the Dialog hemodialysis machine and the Diacap PRO dialyzer.”

The acquisition is subject to Federal Trade Commission approval and contingent upon the closing of the pending merger of NxStage with a subsidiary of Fresenius Medical Holdings Inc. The B. Braun acquisition of the bloodlines business is expected to take place in 2018.

Reference:

www.bbraunusa.com/en/company/newsroom/news/2018/3rd-quarter/b--braun-to-acquire-bloodlines-business-of-nxstage-medical--inc-.html